Writings
The Swiss Army Knife of Health
By Austin Walters
Modern lifestyles are fueling a national sleep crisis, with millions of Americans suffering from chronic sleep disorders and the health risks that follow. In this piece, Austin Walters explores the growing sleep health market and highlights how emerging technologies—from at-home diagnostics to EEG-driven sleep devices—could transform how we understand and improve sleep.
The Housing Crisis is a Health Crisis
By Austin Walters
Housing affordability has become a nationwide crisis with profound health consequences. As rising costs strain family budgets, preventive care and medications are often sacrificed. Evidence from initiatives like UnitedHealth Group’s housing investments shows that stable, affordable housing improves health outcomes, reduces emergency care, and demonstrates how housing policy can directly influence public health.
Size Matters: Funding Ventures in a Healthy Interest Rate Environment
By Austin Walters
As venture markets normalize, smaller fund sizes are regaining favor for their ability to drive stronger returns. Historical data shows large funds rarely achieve top multiples, while smaller funds can deliver outsized performance. Going forward, success will be measured less by scale and more by DPI and disciplined capital deployment in tighter markets.
The Promethean Crisis of AI
By Austin Walters
Using the myth of Prometheus, Austin Walters explores AI as both transformative and dangerous. While AI offers major advances in efficiency and healthcare, it also raises concerns around critical thinking, bias, and ethics. The path forward lies in responsibly guiding AI’s development to maximize its benefits while mitigating its risks to society.
Timing the Market for Early vs. Late Stage Venture Investments
By Austin Walters
Economic cycles impact venture valuations unevenly, with late-stage investments far more sensitive to market timing than early-stage deals. Austin Walters explains that early-stage valuations remain relatively stable, while late-stage companies face greater volatility due to revenue pressures, investor behavior, and macroeconomic shifts, making timing critical for late-stage venture returns.